Financials data is unavailable for this security.
View more
Year on year Bactiquant A/S had relatively flat revenues (12.39m to 12.30m), though the company grew net income from a loss of 14.18m to a smaller loss of 13.10m. A reduction in the selling, general and administrative costs as a percentage of sales from 90.31% to 71.03% was a component in the net income growth despite flat revenues.
| Gross margin | -24.34% |
|---|---|
| Net profit margin | -161.20% |
| Operating margin | -146.80% |
| Return on assets | -82.23% |
|---|---|
| Return on equity | -193.99% |
| Return on investment | -92.65% |
More ▼
Cash flow in DKKView more
In 2023, Bactiquant A/S increased its cash reserves by 226.74%, or 8.21m. Cash Flow from Financing totalled 16.95m or 137.74% of revenues. In addition the company used 8.16m for operations while cash used for investing totalled 581.80k.
| Cash flow per share | -0.5896 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.2906 |
|---|---|
| Tangible book value per share | 0.0674 |
More ▼
Balance sheet in DKKView more
| Current ratio | 4.63 |
|---|---|
| Quick ratio | 2.73 |
| Total debt/total equity | 1.14 |
|---|---|
| Total debt/total capital | 0.5326 |
More ▼
Growth rates in DKK
Year on year, growth in earnings per share excluding extraordinary items increased 11.64%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 1.98 |
